Taiwan · Delayed Price · Currency is TWD Daiken Biomedical Statistics
Total Valuation
TPE:7780 has a market cap or net worth of TWD 13.65 billion. The enterprise value is 8.51 billion.
| Market Cap | 13.65B |
| Enterprise Value | 8.51B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Sep 3, 2026 |
Share Statistics
TPE:7780 has 805.56 million shares outstanding. The number of shares has increased by 28.50% in one year.
| Current Share Class | 805.56M |
| Shares Outstanding | 805.56M |
| Shares Change (YoY) | +28.50% |
| Shares Change (QoQ) | -0.30% |
| Owned by Insiders (%) | 0.44% |
| Owned by Institutions (%) | 1.26% |
| Float | 217.69M |
Valuation Ratios
The trailing PE ratio is 30.78.
| PE Ratio | 30.78 |
| Forward PE | n/a |
| PS Ratio | 6.25 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | 52.14 |
| P/OCF Ratio | 52.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.04, with an EV/FCF ratio of 32.49.
| EV / Earnings | 20.03 |
| EV / Sales | 3.89 |
| EV / EBITDA | 21.04 |
| EV / EBIT | 21.60 |
| EV / FCF | 32.49 |
Financial Position
The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.75 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.45 |
| Interest Coverage | 192.53 |
Financial Efficiency
Return on equity (ROE) is 14.21% and return on invested capital (ROIC) is 13.35%.
| Return on Equity (ROE) | 14.21% |
| Return on Assets (ROA) | 6.26% |
| Return on Invested Capital (ROIC) | 13.35% |
| Return on Capital Employed (ROCE) | 8.01% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.95 |
Taxes
In the past 12 months, TPE:7780 has paid 123.76 million in taxes.
| Income Tax | 123.76M |
| Effective Tax Rate | 22.55% |
Stock Price Statistics
The stock price has decreased by -49.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -49.56% |
| 50-Day Moving Average | 17.42 |
| 200-Day Moving Average | 19.12 |
| Relative Strength Index (RSI) | 51.49 |
| Average Volume (20 Days) | 712,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:7780 had revenue of TWD 2.19 billion and earned 424.96 million in profits. Earnings per share was 0.55.
| Revenue | 2.19B |
| Gross Profit | 1.35B |
| Operating Income | 393.91M |
| Pretax Income | 548.72M |
| Net Income | 424.96M |
| EBITDA | 400.99M |
| EBIT | 393.91M |
| Earnings Per Share (EPS) | 0.55 |
Balance Sheet
The company has 5.26 billion in cash and 116.79 million in debt, with a net cash position of 5.14 billion or 6.39 per share.
| Cash & Cash Equivalents | 5.26B |
| Total Debt | 116.79M |
| Net Cash | 5.14B |
| Net Cash Per Share | 6.39 |
| Equity (Book Value) | 4.87B |
| Book Value Per Share | 6.05 |
| Working Capital | 4.73B |
Cash Flow
In the last 12 months, operating cash flow was 262.60 million and capital expenditures -707,000, giving a free cash flow of 261.89 million.
| Operating Cash Flow | 262.60M |
| Capital Expenditures | -707,000 |
| Depreciation & Amortization | 7.09M |
| Net Borrowing | 96.85M |
| Free Cash Flow | 261.89M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 61.79%, with operating and profit margins of 18.02% and 19.44%.
| Gross Margin | 61.79% |
| Operating Margin | 18.02% |
| Pretax Margin | 25.11% |
| Profit Margin | 19.44% |
| EBITDA Margin | 18.35% |
| EBIT Margin | 18.02% |
| FCF Margin | 11.98% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 4.15%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 4.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 128.54% |
| Buyback Yield | -28.50% |
| Shareholder Yield | -24.36% |
| Earnings Yield | 3.11% |
| FCF Yield | 1.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 9, 2026. It was a forward split with a ratio of 10.
| Last Split Date | Jan 9, 2026 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
TPE:7780 has an Altman Z-Score of 8.77 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.77 |
| Piotroski F-Score | 4 |